Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6 Gastrointestinal 5 Thoracic 3 Genitourinary 3 Lymphoid 2 CNS 2 Plasma cell 1 Other hematologic neoplasm 1 Other 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Uterine Cervical Neoplasms 648 Ovarian Neoplasms 438 Endometrial Neoplasms 289 Breast Neoplasms 178 Uterine Cervical Dysplasia 133 Neoplasms 86 Carcinoma, Ovarian Epithelial 80 Papillomavirus Infections 68 Prostatic Neoplasms 67 Uterine Neoplasms 66 Vulvar Neoplasms 64 Colorectal Neoplasms 59 Fallopian Tube Neoplasms 54 Colonic Neoplasms 47 Peritoneal Neoplasms 45 Pancreatic Neoplasms 45 Lung Neoplasms 45 Urinary Bladder Neoplasms 39 Vaginal Neoplasms 34 Gynecologic Cancer 33 Stomach Neoplasms 32 Head and Neck Neoplasms 31 Hereditary Breast and Ovarian Cancer Syndrome 27 Rectal Neoplasms 26 Pelvic Neoplasms 26 Sarcoma 25 Melanoma 25 Esophageal Neoplasms 25 Recurrence 24 Ovarian Cysts 24

Interventions

Diet, Vegan 1 Angptl4 protein, mouse 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Fasting × Gynecologic × Clear all

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown

BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡